Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the hemodynamics and adverse event profile in
comparison between two treatment arms, one using an admixture of propofol and etomidate at a
ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a
ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the
Clements University Hospital (CUH) endoscopy lab (Endo).